Abstract
The purpose of the research. To develop proposals and recommendations for early diagnosis of muscle hypotonia syndrome in children, development of criteria for determining the level of severity, and determination of treatment measures, improving electrophysiological (ENMG, SEP) diagnostic methods.
In the period of 2022-2023, 110 children of early age (0-3) with muscle hypotonia syndrome were comprehensively examined in the department of "Childhood Nervous Diseases" of the 1st Children's Clinical Hospital of Tashkent City. In our research, we divided the patients with muscle hypotonia syndrome, that is, the representatives of each group (group 1,2,3,4) into 2 groups.
Representatives of the 1st group (47 people): traditional medical treatments, i.e. medical treatment + rehabilitation. Medicinal treatment includes nootropic, blood circulation improving, acetylcholinesterase drugs and group B vitamins. Representatives of the 2nd group (63 people): rPMS + rehabilitation. Treatment procedures were continued every month for 10 days from 3 to 6 months. Patients underwent ENMG and SSChP examination before and after treatment. , in our patients who received rPMS + rehabilitation, ENMG indicators were significantly higher than in patients who received conventional treatment.
In conclusion, rPMS+ rehabilitation resulted in a significant and short-term reduction in the latency period of SSChP peaks, an increase in the conduction of nerve impulses from the somatosensory pathway in response to n. medianus stimulation.
Even when rPMS was applied peripherally, significant efficacy was achieved in improving somatosensory cortical conductance in the SSChP study of patients with central MGS. Our results showed that since rPMS is the hub of spinal cord descending, ascending and segmental nerve signals, non-invasive rPMS has the ability to simultaneously change cortical, corticospinal, spinal cord motor activity and conductance and excitability in peripheral nerves.
Links and resources
Tags